a developer of medical devices used for treatment of the neurological complications of diabetes
Industry MedicalSpecialties
A.I.dvisor tells us that NURO and NNOX have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NURO and NNOX's prices will move in lockstep.
Ticker / NAME | Correlation To NURO | 1D Price Change % | ||
---|---|---|---|---|
NURO | 100% | +0.16% | ||
NNOX - NURO | 26% Poorly correlated | -1.75% | ||
NAOV - NURO | 25% Poorly correlated | +0.69% | ||
ALGN - NURO | 25% Poorly correlated | -7.66% | ||
MASI - NURO | 23% Poorly correlated | +0.47% | ||
NVST - NURO | 23% Poorly correlated | -1.10% | ||
More |